Skip to content

Valuation and dilution

How Do Investors Decide What a Startup Is Worth?

The evidence and risk questions behind a valuation conversation.

August 19, 2026

Read online

Open Note: Read this as a decision framework, not a universal benchmark. The right answer depends on stage, sector, geography, traction, and the capital your company actually needs.

Short answer: Investors decide what a startup is worth by weighing the evidence that the company can become much larger against the risks that could prevent it. They look at the market, team, traction, product, distribution, capital plan, and likely future financing—not one magic metric. Your job is to make the assumptions visible and show why the proposed price is supportable for this stage.

What the question is really asking

When a founder asks what the company is worth, they are usually asking three questions at once: what price could the market accept, how much ownership would a round sell, and whether the business has enough evidence to carry that price into the next round. Those questions are related but not identical.

Valuation is a financing decision under uncertainty. An investor is not buying a spreadsheet output; they are underwriting a range of possible outcomes. A useful valuation conversation therefore explains what is known, what is inferred, and what still has to be proven.

1. Market and outcome potential

Investors first ask whether the company is pursuing a market large enough to support a venture outcome. That does not require a giant top-down number pasted into a deck. It requires a credible explanation of who pays, why the problem is urgent, how the category may expand, and what a meaningful company could look like.

Make the market specific to your wedge. Name the first customer segment, the buying motion, the competitive alternatives, and the reason the company can expand beyond its initial niche.

2. Evidence of demand

Traction is evidence that customers are changing behavior, not simply a collection of flattering anecdotes. Depending on the business, that evidence may include revenue, retention, usage frequency, paid pilots, conversion, pipeline quality, or repeatable distribution.

State the period and definition for every important metric. A claim such as growing quickly is weak without a starting point, end point, cohort definition, and explanation of what caused the change.

3. Team and execution fit

The team matters because early-stage valuation includes a judgment about execution. Investors look for relevant insight, speed of learning, founder-market fit, and the ability to recruit the capabilities the company does not yet have.

Be precise about gaps. Saying that the team is complete can be less credible than explaining which hire the round funds, why it matters, and what work the founders can cover in the meantime.

4. Risk and financing structure

Risk affects price because it affects the probability that future capital will be available. Regulatory exposure, customer concentration, technical dependencies, long sales cycles, or a capital-intensive model may all change how an investor underwrites the round.

The instrument also matters. A SAFE cap, discount, option-pool treatment, pro rata right, or liquidation preference can change the economics even when the headline valuation sounds attractive.

5. Capital plan and next milestone

A valuation is more persuasive when it is connected to a specific use of funds and a credible milestone plan. Show what the round buys, how long it lasts, what evidence should exist at the next financing decision, and what happens if the milestone takes longer.

Worked example: an evidence-backed range

Imagine a startup with $900,000 in annual recurring revenue, 88% gross retention, and a sales process that is improving but still founder-led. The founders want to raise $2 million. They compare a $6 million, $8 million, and $10 million pre-money case. These numbers are illustrative, not a market benchmark or prediction.

At each case, they model ownership sold, option-pool needs, runway, and the evidence required for the next round. The lower price may create more immediate dilution but a more attainable milestone bar. The higher price may preserve ownership today but create more pressure if growth depends on an unproven channel. The decision is the price-and-plan combination the company can realistically carry.

Founder decision

Prepare a valuation memo with the evidence, assumptions, financing terms, downside case, and alternatives. Then ask whether the proposed price helps the company finance the next proof point without narrowing its future options. Raising less, waiting, using revenue, or choosing another instrument may be the stronger decision.

When not to follow this advice

Do not use a single comparable company, online valuation table, or recent headline round as a substitute for context. Comparables can be stale, selectively reported, or structurally different. If you cannot explain the evidence behind a price, treat the price as a negotiation hypothesis rather than a fact.

A useful next step

Use the SAFE + Dilution Decoder to test how a proposed price and instrument affect ownership across scenarios.

Disclosure: This is general educational information for founders, not legal, tax, accounting, investment, or financial advice. Illustrative numbers are examples only.

The Raise Memo

Want a clearer answer for your company?

SAFE + Dilution Decoder

Understand how a SAFE converts and what ownership is left afterward.

Open the tool — free

Originally published in The Raise Memo.